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Abstract
Background: Recent genomic scale survey of epigenetic states in the mammalian genomes has
shown that promoters and enhancers are correlated with distinct chromatin signatures, providing
a pragmatic way for systematic mapping of these regulatory elements in the genome. With rapid
accumulation of chromatin modification profiles in the genome of various organisms and cell types,
this chromatin based approach promises to uncover many new regulatory elements, but
computational methods to effectively extract information from these datasets are still limited.
Results: We present here a supervised learning method to predict promoters and enhancers
based on their unique chromatin modification signatures. We trained Hidden Markov models
(HMMs) on the histone modification data for known promoters and enhancers, and then used the
trained HMMs to identify promoter or enhancer like sequences in the human genome. Using a
simulated annealing (SA) procedure, we searched for the most informative combination and the
optimal window size of histone marks.
Conclusion: Compared with the previous methods, the HMM method can capture the complex
patterns of histone modifications particularly from the weak signals. Cross validation and scanning
the ENCODE regions showed that our method outperforms the previous profile-based method in
mapping promoters and enhancers. We also showed that including more histone marks can further
boost the performance of our method. This observation suggests that the HMM is robust and is
capable of integrating information from multiple histone marks. To further demonstrate the
usefulness of our method, we applied it to analyzing genome wide ChIP-Seq data in three mouse
cell lines and correctly predicted active and inactive promoters with positive predictive values of
more than 80%. The software is available at http://http:/nash.ucsd.edu/chromatin.tar.gz.
Background
Transcriptional regulation in eukaryotic cells requires
highly orchestrated interactions between transcription
factors (TFs), their co-factors, RNA polymerase and the
chromatin [1,2]. Several classes of regulatory elements,
including promoters, enhancers, silencer and insulators,
are involved in this process. Systematic and precise map-
ping of these elements in the genome is essential for
understanding transcriptional programs responsible for
temporal and tissue specific gene expression. A high
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throughput experimental approach has recently been
used to tackle this problem and it involves the chromatin
immunoprecipitation assay followed by microarray
(ChIP-chip)[3,4] or large scale sequencing (ChIP-Seq)[5-
8]. Currently, this approach is still limited by the availa-
bility of antibody specifically recognizing individual TFs
at different regulatory elements. Another method involves
comparative genomic analysis of related genomes[9,10]
and clustering of multiple sequence motifs[11-13]. This
approach has been successfully applied to a number of
eukaryotic genomes including yeast, Drosophila and
mammal genomes (see review, for example, [14]). These
methods rely on precise alignment of regulatory elements
across multiple genomes which is not necessarily true for
all elements, or prior knowledge of a set of cooperative
TFs which is not always available.
Recently, a chromatin based regulatory element mapping
approach has been proposed[15]. This approach exploits
the observation that transcriptional promoters and
enhancers are associated with distinct chromatin signa-
tures. Specifically, the active promoters are characterized
by tri-methylation on Lys4 in H3 (H3K4me3), while the
active enhancers are associated with mono methylation of
this residue and a much reduced or non-existent signal of
the tri-methylation [15]. Currently, it is not yet clear what
mechanisms underlie the different chromatin signatures
at these two classes of cis-regulatory sequences, but the
characteristic chromatin signatures of regulatory elements
provide a pragmatic way to systematically identify these
elements in the genome without prior knowledge of the
underlying sequences. Compared with the other methods,
there are several advantages of this chromatin-based
approach. First, it requires no prior knowledge of the
sequence features of the promoters or enhancers; Second,
the chromatin modification profiles could be obtained for
most organisms as the existing antibodies can specifically
recognize the characteristic histone modifications in dif-
ferent species. Third, this approach does not make the
assumption that promoters or enhancers are evolutionar-
ily conserved, thereby can identify fast evolving regulatory
elements in the genome.
Distinct chromatin signatures at promoter and enhancers
have been explored by Heintzman et al[15] to map pro-
moters and enhancers. In their study, ChIP-chip analysis
using high-resolution tiling array was performed to local-
ize the core histone H3 (referred as H3) and monitor the
status of five histone modification marks, i.e. H4 acetyla-
tion (H4ac), H3 acetylation (H3ac), mono-, di- and tri-
methylation of Lys4 in H3(H3K4me1, H3K4me2 and
H3K4me3) in HeLa cells before and after treatment with
interferon-gamma (IFN). In addition, binding sites for
components of transcription machinery (RNAPII and
TAF1) and p300 (a transcriptional co-activator) were
identified to locate active promoters and enhancers,
respectively. Using these functional sites, Heintzman et
al[15] determined characteristic chromatin modification
profiles at the promoters and enhancers – promoters have
both H3K4me1 and H3K4me3 marks in contrast to the
prominent H3K4me1 presence at enhancers with much
reduced H3K4me3 signal. Using the average profiles of
the promoters and enhancers as templates, Heintzman et
al. identified additional genomic regions sharing similar
profiles and confirmed that many of the predictions
indeed correspond to promoters and enhancers. Figure 1
shows the averaged profile of the histone profiles they
studied. By comparing the prediction performance of all
possible combinations of the six histone marks using
cross-validation, they concluded that the combination of
H3K4me1 and H3K4me3 best discriminated promoters
from enhancers.
In spite of the success of this profile-based method in pre-
dicting promoters and enhancers, it is limited in two
aspects. First, the optimal performance of the method
involves only two histone modification marks, therefore
the prediction accuracy was sensitive to the noise of meas-
urements of these two marks. The contribution of other
chromatin modifications marks to the classification
method and the interdependency of the histone marks
were not considered. Second, the window size of histone
modification patterns (10 kb) was chosen in an arbitrary
way. The larger the window size, the smaller the portion
of the central regions with the strongest signal intensity.
Thus, the profiles built for the promoter/enhancer may
not be optimal. Figure 2(A) shows examples of histone
modification patterns and annotated genes in human
chromosome 1. The TSSs of these genes are well aligned
with strong histone patterns of promoters. The profile-
based method by Heintzman et al. correctly identified the
promoter near chr:148185131 but not the one near
chr1:148158254 because of the relatively weak H3K4me3
signal. An enhancer was also identified close to
chr1:148158254 because of weak H3K4me3. In Figure
2(B) a DHS region and a p300 binding peak overlap at
chr6:132486009, showing strong evidence of enhancer.
Since the H3K4me3 signal is relatively stronger than a typ-
ical enhancer profile which almost has no signal, the pro-
file based method missed this site. Another example near
chr8:119170000 shows weak pattern of H3K4me3, which
misleads the prediction (Figure 2(C)).
To overcome the above limitations, we developed a
method coupling HMM with simulated annealing (SA)
[16] (a HMM-SA procedure) to identify promoters and
enhancers based on chromatin signatures. The HMM is
capable of extracting more information from the chroma-
tin modification profile signals, is less sensitive to the
measurement noise of an individual histone mark, andBMC Bioinformatics 2008, 9:547 http://www.biomedcentral.com/1471-2105/9/547
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can automatically select the most informative combina-
tion of histone marks as well as the optimal window size.
In each run of SA we trained HMMs[17,18] using the 105
promoters and 73 enhancers determined by the ChIP-
chip experiments on RNAPII, TAF1 and p300[15]. Inside
each HMM, the histone patterns are regarded as continu-
ous observation densities emitted from the HMM states.
The number of histone patterns is the input dimension of
the HMM. The optimal combination and window size of
histone modifications to discriminate promoters from
enhancers were searched using the HMM-SA procedure.
We then used the trained HMMs to predict promoters and
enhancers in the entire ENCODE regions. Below, we
describe this method and the results comparing the per-
formance of our new method with the previous method.
We also demonstrated that including more histone marks
can further boost the performance of our method, which
is also distinct from the profile-based method. In addi-
tion, we showed the usefulness of our method on predict-
ing the activity of promoters in the mouse genome using
histone modification data generated by ChIP-Seq [8].
Results and discussion
Find the most informative combination and the optimal 
window size of histone modifications
To characterize chromatin signature of promoters and
enhancers, one needs to define the histone modifications
that can discriminate different regulatory elements. Since
the chromatin signals from ChIP-chip analysis typically
span thousands of base pairs, a small window may not
fully capture the chromatin signature while a large win-
dow may include non-informative regions to deteriorate
Histone modification patterns of promoters and enhancers in untreated HeLa cells Figure 1
Histone modification patterns of promoters and enhancers in untreated HeLa cells. This figure is re-generated 
from Heintzman et al [15]. All signals of six histone marks are drawn centered on TSSs and p300 binding peaks. Average signal 
of histone marks of TSS and enhancers are drawn in black.BMC Bioinformatics 2008, 9:547 http://www.biomedcentral.com/1471-2105/9/547
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Examples of histone modification patterns in promoters and enhancers Figure 2
Examples of histone modification patterns in promoters and enhancers. (A) Promoter prediction using chromatin 
signature. TSS near chr1:148185131 shows a typical histone modification pattern for promoter while H3K4me3 has a relatively 
weak signal for the TSS near chr1:148158254. The predictions made by the profile based method of Heintzman et al. are 
labeled in green and the predictions made by the HMM developed in this study are in red. (B) Enhancer prediction using chro-
matin signature. A p300 binding site is shown at chr6:132486009 and overlaps with a DHS site, which is a strong evidence to 
support an enhancer site. (C) Enhancer prediction using chromatin signature. A DHS site near chr8:119170000 overlaps with a 
weak H3K4me3 signal but is not found as an enhancer by the profile-based method.BMC Bioinformatics 2008, 9:547 http://www.biomedcentral.com/1471-2105/9/547
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the prediction accuracy. Therefore, an optimal window
size is critical in predicting promoters and enhancers
using histone modification patterns. To find the most
informative combination and the optimal window size,
we coupled the hidden Markov model (HMM) with sim-
ulated annealing (SA) [16] (see Methods).
To compare with the profile-based method, we consid-
ered the 105 promoters and 73 enhancers determined by
the ChIP-chip experiments on RNAPII, TAF1 and p300 in
the Heintzman et al. study[15]. The datasets were divided
into two equal sets, one for training and one for evalua-
tion. The HMM-SA procedure started with a random com-
bination of histone marks and a random window size
chosen from 1, 2, 4, 6, 8, 10 and 12 kb centered on the
TSSs or p300 peaks. We have conducted 100 independent
simulations and collected all the final outputs of the com-
binations of histone marks and the window size.
We found the window size of 2 kb to be the optimal win-
dow size in 75 out of 100 simulated annealing runs. As
shown in Figure 1 the strongest and the most informative
signals are close to the center but 1 kb-window may be too
small to capture the characteristic patterns. We also exam-
ined the occurrence of histone modification combina-
tions in the 100 runs and compared their prediction
accuracy on the evaluation set of 53 promoters and 37
enhancers (Table 1). The combination of all six marks was
selected by the HMM-SA procedure 43 times, which is
much higher than the other combinations. This observa-
tion is not totally unexpected because more information
is included when including more histone marks. We also
observed that the prediction accuracies for different com-
binations of multiple histone modifications are compara-
ble with that of all six marks, which may be due to the
small data set we have and the dependency of HMMs on
the initial conditions. The combination of all six histone
marks was chosen most often because it has higher chance
to get better result in the SA test and insensitive to the
choice of initial conditions. For a larger dataset for train-
ing and evaluation, the differences between the prediction
accuracies of different histone mark combinations are
expected to be more significant.
Among the pair combinations, the H3K4me1 and
H3K4me2 pair was chosen six times while the combina-
tion of H3K4me1 and H3K4me3 was not found by HMM-
SA. Examining the histone modification patterns (Figure
1), it is obvious that H3K4me2 is more informative to
locate enhancers than H3K4me3 because H3K4me2
shows stronger signal around p300 binding sites than
H3K4me3. Since we did not just classify promoter against
enhancer but rather we predicted promoter/enhancer
against background, H3K4me2 was selected more often
than H3K4me3. We next examined which single histone
modification is the most informative by simply counting
how many times a histone mark was included in the final
combination (Table 2). Consistent with the above obser-
vation, H3K4me1 and H3K4me2 turned out to occur
most often (99 and 97 times, respectively). This is not sur-
prising because on average these two marks have the
strongest signal among all six histone modifications (Fig-
ure 1). H3 was included 76 times even though its signal is
relatively weak, which is surprising at the first glance. Fur-
ther examination of H3 signals showed that they are con-
sistent and well aligned (Figure 1), which makes it
informative in the sense to help locate the center of pro-
moter/enhancer.
Cross validation shows that HMM method predicts 
enhancers more accurately than the profile-based method
Using the optimal combination and the window size the
HMM-SA procedure found, we conducted five-fold cross-
validation tests to compare the performance of the pro-
posed method with the profile-based method[15]. There
were 105 promoter and 73 enhancer profiles in our anal-
ysis (see Methods). We used three hidden states to train
the HMM for promoters and enhancers separately (see
Methods). In total, we performed 30 independent cross-
validation tests and the averaged results are shown in
Table 3. The HMM and the profiles-based method have a
comparable accuracy on predicting promoters (positive
predictive value (PPV = TP/(TP+FP)) = 97.87 ± 1.06% ver-
sus 96% using all six histone marks). In contrast, signifi-
cant improvement over the profile-based method was
indeed observed on enhancer prediction: 93.52 ± 1.83%
using all the six histone marks by the HMM versus 78%
using all six marks or 85% using H3K4me1 and H3K4me3
by the profile-based method. It is not surprising that the
HMM using all six marks outperforms the profile-based
method using only H3K4me1 and H3K4me3 because
more information is included by using more marks. How-
ever, as shown by Heintzman et al., the profile-based
method achieved the best performance using two but not
all the six marks. This may explain that the HMM can cap-
ture the characteristic pattern better than using profile,
particularly for enhancers that have relatively weaker sig-
nals than promoters. This is further supported by the
observation that the HMM using only H3K4me1 and
H3K4me3 still achieved much higher prediction accuracy
on enhancers than the profile-based method (PPV = 94.06
± 0.89% in Table 3).
Analysis on the trained HMM
After we validated the HMM model using cross-valida-
tions, we further examined the probability density distri-
bution of each state in the HMM. The 3-state HMMs with
no backward transition were trained on promoters and
enhancers separately. This type of structures without back-
ward transitions has been widely used in speech recogni-BMC Bioinformatics 2008, 9:547 http://www.biomedcentral.com/1471-2105/9/547
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tion to capture the pattern of speech [17]. The second state
usually corresponds to the location of TSS or p300 peaks
in this configuration. The first and the third states corre-
spond to the upstream and downstream profiles of chro-
matin modifications, respectively. Figure S1 (A,B,C,D,E,F)
(see Additional files 1, 2, 3, 4, 5, 6) shows the probability
density of Gaussian mixtures for the three states of every
chromatin mark on promoters and enhancers. It is obvi-
ous that promoters and enhances present differences in
distributions of probability density, which reflects the
chromatin modification patterns in these regions. For
example, the probability density of H3K4me3 showed
peaks in the high ChIP-chip ratio regions for promoters
compared to peaks in the low ratio regions for enhancers
Table 1: The results of 100 HMM-SA runs.
Combination
H4ac, H3ac, H3Kme1, H3K4me2, H3K4me3, H3 43 98.8%/94.5%
H3Kme1, H3K4me2, H3K4me3, H3 8 99.1%/93.2%
H4ac, H3ac, H3Kme1, H3K4me2, H3 6 99.1%/94.1%
H3Kme1, H3K4me2 6 99.7%/92.8%
H4ac, H3Kme1, H3K4me2, H3K4me3, 5 100%/93.5%
H3Kme1, H3K4me2, H3K4me3, H3 5 100%/93.0%
H3ac, H3Kme1, H3K4me2, H3K4me3, H3 5 99.2%/94.6%
H3Kme1, H3K4me2, H3K4me3 5 99.6%/94.6%
H4ac, H3Kme1, H3K4me2, H3 4 100.0%/93.2%
H4ac, H3ac, H3Kme1, H3K4me2, H3K4me3 3 98.1%/94.6%
H4ac, H3Kme1, H3K4me2 3 100%/94.6%
H4ac, H3ac, H3Kme1, H3K4me3, H3 2 97.2%/93.2%
H3Kme1, H3K4me2, H3 2 100.0%/93.2%
H4ac, H3K4me3 1 96.2%/91.9%
H3ac, H3Kme1, H3K4me2 1 98.1%/94.6%
H3ac, H3Kme1, H3K4me2, H3 1 100.0%/94.6%
Window Size Number of times used Prediction rate (promoter/enhancer)
1 K 8 99.3%/93.6%
2 K 75 99.0%/94.3%
4 K 7 99.7%/93.4%
8 K 7 99.5%/93.1%
10 K 2 100%/91.9%
12 K 1 98.1%/89.2%BMC Bioinformatics 2008, 9:547 http://www.biomedcentral.com/1471-2105/9/547
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(Figure S1(E), see Additional file 5). In addition, examin-
ing the probability density distribution of the three states
in the promoters suggested that the HMM model also cap-
tured the characteristics of the chromatin modification
profiles. The probability density functions of the third
state for H3K4me3 were peaked around 2.5 of ChIP-chip
log ratio. The second state and the first state peaked at low
ChIP-chip ratios with lower probability. This is indeed a
bimodal pattern with higher ChIP-chip ratios on the
downstream, which is consistent with the finding in the
previous study [15].
Promoter prediction in the ENCODE regions
We then applied our model to predicting promoters in the
entire ENCODE regions of HeLa cells before and after
treatment with IFN. We examined the classification per-
formance of the HMM classifier by counting how many
promoter predictions were supported by the annotated
TSSs [19], CAGE tags [20] and active promoters [21]. We
compared the results with the promoter predictions of
Heintzman et al. They reported 198 and 208 TSS predic-
tions in the untreated and IFN treated HeLa cells in the
ENCODE regions [15]. Figure 3 plots the number of pre-
dictions supported by the annotated TSSs against the total
number of predictions by varying the cutoff c1 from 0.4 to
3.5 (see Methods). We observed the same number of pro-
moter predictions as the profile-based method at the cut-
off (c1) of 2.205 in the untreated HeLa cells, and at c1 = 2.1
in the treated cells (Table 4). We found that 77% and 73%
of predictions by the HMM and the profile based method
were common for the untreated and treated cell, respec-
tively (Table 4). The HMM method (PPV = 189/198 =
95.45%) did outperform the profile-based method (PPV
= 181/198 = 91.41%). The HMM method predicted more
annotated TSSs when the PPV of the two methods were
similar to each other: in the untreated cell PPV = 234/256
= 91.41% and in the treated cells PPV = 247/279 =
88.50%. When we further increased the number of predic-
tion the total number of correct predictions reached to
around 270 TSSs using the HMM method, while the max-
imum number of the correct prediction of the profile
method was 190 correct predictions (Figure 3).
CAGE tags[20] have been generated to map promoters
and we investigated if the predicted TSSs were supported
by CAGE tags. Ideally, only one CAGE tag is needed to
map a promoter. But due to the noise of generating the
tags, confident promoter are usually supported by the
overlapping with multiple tags. The larger the number of
CAGE tags overlap with the predicted promoters, the
more confident the predictions are. We counted the
number of predicted promoters supported by at least 5,
10, and 15 CAGE tags. We predicted 198 and 208 promot-
ers in the untreated and the treated cells, respectively, for
both the HMM and the profile-based method (Figure 4).
When the CAGE tag cutoff was 5, the HMM method found
192 (PPV = 96.97%) and 201 (PPV = 96.63%) promoters
supported by CAGE tags in the untreated and the treated
cell, respectively, compared with 184 (92.9%) and 180
(86.5%) supported predictions by the profile-based
method, respectively. It is not surprising that the number
of the supported promoters decreased when we increased
the minimum number of overlapping CAGE tags. We
found that the performance improvement of the HMM
over the profile-based method was more significant in the
treated cells. Considering both methods were trained
using the untreated data, it suggests that the HMM
method is more robust than the previous method.
We next compared the performance of the two methods
on predicting active promoters. Gene expression measure-
ments[21] showed that there were 177 active and 155
Table 3: Comparison of cross-validation results for predicting promoters and enhancers.
Combination Promoter PPVa (standard deviation) Enhancer PPV (standard deviation)
HMM method using 6 histone signaturesb 97.87% (1.06) 93.52%(1.83)
HMM method using 2 histone signaturesc 95.46% (2.82) 94.06% (0.89)
Heintzman et al. using 6 histone signatures 96% 78%
Heintzman et al. using 2 histone signatures 95% 85%
aPositive predictive value (PPV) = true prediction/(true prediction + wrong prediction) and standard deviation are calculated.
b6 histone signatures: H4ac, H3ac, H3Kme1, H3K4me2, H3K4me3, H3
c2 histone signatures: H3Kme1, H3K4me3
Table 2: Occurrence of each histone modification in the most 
informative combinations found by the 100 HMM-SA runs.
H4ac H3ac H3K4me1 H3K4me2 H3K4me3 H3
75 61 99 97 77 76BMC Bioinformatics 2008, 9:547 http://www.biomedcentral.com/1471-2105/9/547
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inactive promoters in the untreated HeLa cells, and 181
active and 151 inactive promoters in the treated cells. The
profile based method detected 127 active and 31 inactive
promoters in the untreated cells (Table 5). The two meth-
ods correctly predicted similar number of active promot-
ers (127 and 128) when the number of predictions was
around 200. While increasing the number of predictions,
the profile based method did not but the HMM method
did make more correct predictions of active promoters in
both treated and untreated cells (Table 5).
We investigated the sensitivity and specificity of each
method (for the definition see Methods). Figure 5 shows
the receiver operator characteristic (ROC) curves of the
HMM and the profile-based methods in the untreated and
treated cells. Both methods achieved good performance
with high sensitivity and specificity but the performance
improvement of the HMM method is prominent.
Enhancer prediction in the ENCODE regions
We also used the trained HMM to predict enhancers in the
ENCODE regions. We found 319 (82.01%) and 243
(75.00%) common enhancers predicted in the untreated
(389 predictions) and treated cells (324 predictions),
respectively, by the HMM method and the profile-based
method with the same number of total predictions. To
compare the performances of the two methods, we
checked how many of them were supported (within 2.5
kb) by nearby p300 and TRAP200 binding sites as well as
DNase hypersensitivity sites (DHSs). p300 is a transcrip-
tional co-activator[22,23]. TRAP220 is a component of
the Mediator complex[22,23] that have been shown to
bind to enhancers as well as promoters. DHSs are nucleo-
some free regions that are often occupied by enhancers
[24]. We only considered p300, TRAP220 and DHS sites
that are distal (> 2.5 kb) from any TSS to avoid confusion
with promoters.
In the untreated HeLa cells, all three sites have been
mapped in the ENCODE regions. We calculated sensitiv-
ity = TP/(TP+FN) of the two methods (Table 6). More pre-
dictions by the HMM method were supported by any and
all of the three lines of evidences. In total, 213 out of 389
predictions by the HMM method were supported (PPV =
54.76%) by any of the three evidences, while the profile-
based method made 206/389 = 52.96% supported predic-
tions (Table 6 and Figure 6b). We should point out that
there may exist true enhancers among the predicted ones
by HMM but not supported by the p300, DHS or
TRAP220 data. This may explain the relatively smaller
improvement of our method over the profile-based
method on enhancer predictions than on promoter pre-
dictions.
In the treated cell, only p300 binding data was available
and it was used to evaluate the predictions of the two
Table 4: Comparison of PPV = TP/(TP+FP) in promoter predictions using the annotated TSS sites.
Untreated
Total Prediction (TP+FP) TP PPV p-value
Heintzman et al. 198 181 91.41% < 1.0 × 10-16
HMM(c1 = 2.205) 198 189 95.45% < 1.0 × 10-16
HMM (c1 = 1.6) 256 234 91.41% < 1.0 × 10-16
HMM (c1 = 0.5) 337 264 78.34% < 1.0 × 10-16
Treated
Total Prediction (TP+FP) TP PPV p-value
Heintzman et al. 207 183 88.41% < 1.0 × 10-16
HMM (c1 = 2.1) 207 196 94.69% < 1.0 × 10-16
HMM (c1 = 1.367) 279 247 88.50% 2.8 × 10-3
HMM (c1 = 0.5) 362 278 76.80% < 1.0 × 10-16
We calculated p value by generating random predictions on the ENCODE regions.BMC Bioinformatics 2008, 9:547 http://www.biomedcentral.com/1471-2105/9/547
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methods. While Heintzman et al. had 104 out of 318 pre-
dictions overlapping with p300 sites (sensitivity = 104/
147 = 70.75%, PPV = 32.70%), the HMM method found
109, out of 288, p300-supported predictions (sensitivity =
76.22%, PPV = 37.85%). Again, the HMM method out-
performed the profile-based method in this test set.
Including additional histone marks can further improve the 
performance of the HMM method
Recently, Hon et al. conducted the same ChIP-chip exper-
iments on more histone modification marks, H3K9Ac,
H3K18Ac, H3K27Me3 and H3K27Ac, in the ENCODE
regions[25]. A robust method should achieve better per-
formance when including additional data. We applied the
HMM method to this larger dataset and evaluated its per-
formance as above. After training the HMM predictor
using all ten histone marks and a window size of 2 kb,
same as in the six histone mark dataset, we predicted pro-
moters and enhancers in the ENCODE regions. We
observed a significant improvement in the promoter pre-
dictions (Figure 6a). The HMM method using 10 histone
marks was quite close to the ideal line even when other
methods reached plateau. For example, the HMM made
291, out of 341, correct predictions (PPV = 291/341 =
85.34%) using 10 histone marks and only 264 out of 337
Promoter predictions supported by CAGE tags Figure 4
Promoter predictions supported by CAGE tags. We 
compared the number of predicted promoters supported by 
CAGE tags when changing the minimum number of CAGE 
tags found within 2.5 kb from the predicted TSSs. We com-
pared the results when the HMM method made same 
number of predictions as the profile-based method 
(untreated cells: 198 predicted sites, treated cells: 208 pre-
dicted sites).
CAGE tags cut−off
T
P
HMM method (untreated)
Heintzman et al.(untreated)
HMM method (treated)
Heintzman et al.(treated)
51 0 1 5
1
4
0
1
5
0
1
6
0
1
7
0
1
8
0
1
9
0
2
0
0
2
1
0
True positives (TPs) versus the total number of promoter  predictions (a) in the untreated and (b) in the treated HeLa  cells Figure 3
True positives (TPs) versus the total number of pro-
moter predictions (a) in the untreated and (b) in the 
treated HeLa cells. The TF was calculated at different cut-
off values of the log-odds (see Methods). Ideal predictors are 
shown with a black line.BMC Bioinformatics 2008, 9:547 http://www.biomedcentral.com/1471-2105/9/547
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correct predictions using 6 histone makers. Such improve-
ment became more significant when more predictions
were made.
The performance of the HMM method on enhancer pre-
diction was also improved using more histone marks (Fig-
ure 6b). For example, 232 enhancers were correctly
predicted (PPV = 54.46%) using the 10 histone marks,
compared with 226 correct predictions (53.05%) among
the same number (426) of the total predictions using the
6 histone marks. The improvement was not as significant
as in the case of the promoters. It is possibly because the
evidences of true enhancers (p300/TRAP200 binding and
DHS sites) are not as direct as those for the promoters (the
annotated TSSs were determined using full length cDNA).
Prediction of active and inactive promoters using genome-
wide ChIP-Seq data
Compared with ChIP-chip, ChIP-Seq is more costly effec-
tive and probably also less noisy on mapping chromatin
modifications at the genome-wide scale. We investigated
how well our method works with the ChIP-Seq data gen-
erated by Mikkelsen et al. in the three mouse cell lines[8]:
embryonic stem (ES) cells, neural progenitor cells (NPCs)
and embryonic fibroblasts (MEFs). We first compared the
patterns of the four histone marks, H3K4me3, H9K4me3,
H3K27me3, and H3K36me3, around TSSs because these
four marks were measured in all the three cell lines. We
assigned each promoter to one of the four groups based
on the gene expression level measured in the same
study[8]. We averaged the sequencing read counts of each
group around TSS. The active and inactive promoters
exhibit distinct patterns of all but H3K9me3 marks (Fig-
ure S2, see Additional file 7). Strong signals of H3K4me3
in the active promoters and H3K27me3 in the inactive
promoters are consistent with their known functions.
H3K36me3, a mark for transcriptional elongation, shows
a quite spread out pattern around TSS.
Table 5: Comparison of active promoter predictions.
untreated cella
Active promoters Inactive promoters
Total Prediction Expression Supported Prediction PPV
Heintzman et al. [15]b 197 127 64.47% 31
229 127 55.46% 32
HMM (c1 = 1.95) 197 128 64.97% 25
HMM (c1 = 1.6) 229 135 58.95% 31
HMM (c1 = 0.5) 309 143 46.28% 40
treated cella
Active promoters Inactive promoters
Total Prediction Expression Supported Prediction PPV
Heintzman et al. [15] 204 128 62.75% 23
213 128 60.09% 23
HMM (c1 = 1.853) 204 128 62.75% 19
HMM (c1 = 1.367) 247 139 56.27% 22
HMM (c1 = 0.5) 328 145 44.21% 30
aThe total numbers of predictions in Table 5 are slightly different from Table 4 because when multiple predicted sites were supported by the same 
TSS or any enhancer evidence, we merged these predictions (see Methods).
bThe number of correctly predicted active promoters did not change using a lower cut-off in the profile-based method.BMC Bioinformatics 2008, 9:547 http://www.biomedcentral.com/1471-2105/9/547
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Next, we trained two HMMs on 200 active and 200 inac-
tive promoters randomly selected from the ES cell and
predicted the promoters in all three cell lines. Because the
active promoters contain stronger chromatin modifica-
tion signals (more sequencing reads) than the inactive
promoters, our method predicted more active promoters
than inactive ones. The majority of the predicted promot-
ers were within 2.5 kb of the annotated RefSeq TSSs (Table
7): > 81% for active promoters and > 66% for inactive pro-
moters. For the predictions located more than 2b from the
annotated TSSs, these sites can be unannotated promoters
or false positives. We then assessed the prediction accu-
racy of our model using gene expression. Among the genes
that could be unambiguously called active or inactive, our
ROC curves of the HMM and profile-based methods in the untreated and treated cells Figure 5
ROC curves of the HMM and profile-based methods in the untreated and treated cells.BMC Bioinformatics 2008, 9:547 http://www.biomedcentral.com/1471-2105/9/547
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Comparison of (a) promoter and (b) enhancer prediction Figure 6
Comparison of (a) promoter and (b) enhancer prediction. The prediction results using 10 histone marks are compared 
with those using 6 histone marks.BMC Bioinformatics 2008, 9:547 http://www.biomedcentral.com/1471-2105/9/547
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method correctly predicted the activity of the majority of
the promoters. Considering the scale of our predictions,
the PPVs of both active and inactive promoter predictions
(expression supported) are satisfactory: > 88% and  74%,
respectively, for the two classes.
Conclusion
We present here an HMM method to predict promoters
and enhancers using their characteristic histone modifica-
tion patterns. We used a HMM-SA procedure to automat-
ically select the most informative and the optimal window
size of histone modifications. We showed that the more
histone marks are considered, the better the performance
of the HMM can achieve. We compared the HMM method
with the best prediction results using the profile-based
method in the Heintzman et al. study. The cross-valida-
tion test showed that the HMM method performed better
than the profile-based method, especially in the enhancer
classification (Table 3). This observation suggests that the
HMM method has a better capability to learn complicated
patterns particularly for the weak signals around enhanc-
ers. Because correct identification of distal enhancers is
critical in deciphering transcriptional regulation, this fea-
ture of HMM gives it an edge over the profile-based
method.
We also found that the window size of 2 kb gave the best
balance between inclusion of sufficiently strong signals
Table 7: Predicted active and inactive promoters in the mouse genome.
Active Promotera
Cell lines Active Gene Total Prediction Refseq Supported PPV Predicted promoters not present in the 
expression measurement
Expression Supported PPV
ES 7887 13853 81.4% 7191 88.6%
MEF 8092 11913 88.1% 5480 92.3%
NPC 7413 12700 84.1% 6259 89.0%
Inactive Promoterb
Cell lines Inactive Gene Total Prediction Refseq Supported PPV Predicted promoters not present in the 
expression measurement
Expression Supported PPV
ES 4753 2862 77.0% 1806 79.2%
MEF 4248 4301 66.1% 3061 74.6%
NPC 5259 422 73.2% 267 94.8%
a Active promoter supported by gene expression and Refseq: TP is the number of active genes prediction as active and FP is the number of inactive 
genes predicted as active. b Inactive promoter supported by gene expression: TP is the number of inactive genes predicted as inactive and FP is the 
number of active genes predicted as inactive. In both cases, we only considered predictions located within 2.5 Kb to annotated genes and the total 
number of predictions is thus usually larger than the sum of TPs and FPs. Refseq supported PPV shows how much percent of the total active/
inactive promoter predictions are supported by Refseq.
Table 6: Comparison of enhancer predictions in the untreated Hela cells.
Heintzman et al. [15] total 389 prediction HMM method total 389 prediction
distal p300 (n = 94) 77 (sensitivity = 81.91%) 82 (sensitivity = 87.23%)
distal DHS (n = 587) 165 (sensitivity = 28.11%) 179 (sensitivity = 30.49%)
Distal TRAP220 (n = 77) 43 (sensitivity = 55.84%) 47 (sensitivity = 61.04%)
Any of distal (DHS, p300, TRAP220) 206 (PPV = 52.96%) 213 (PPV = 54.76%)
Sensitivity = (TP/(TP+FN)) or PPV = (TP/(TP+FP)) was calculated.BMC Bioinformatics 2008, 9:547 http://www.biomedcentral.com/1471-2105/9/547
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and exclusion of non-informative ones that undermine
the prediction accuracy. However, the improvement of
using a 2 kb window instead of 10 kb was rather small
compared to the use of HMM (Table 1). It suggests that
the improvement in classification is mainly from the
HMM's ability to capture the characteristic patterns of his-
tone modifications for multiple marks.
We demons trated that the HMM method outperforms the
previously developed profile-based method on predicting
promoters and enhancers using chromatin signatures,
particularly on the independent test dataset in the HeLa
cells treated with IFN. The profile-based method per-
formed well with small number of predictions. It reached
the maximum true positives (TPs) when the number of
promoter predictions was about 230 (Table 4 and Figure
6). Beyond 230, TPs almost do not increase with the
number of predictions. In contrast, the HMM method
keeps making correct predictions and it outperformed the
profile-based method even more significantly (Figure 6).
The improvement in enhancer prediction is not signifi-
cant (Figure 6), which may be due to the limited knowl-
edge of enhancer positions in the genome. We only
evaluated the prediction accuracy using the DHS and the
binding sites of p300 and TRAP220 that may miss many
enhancers.
The HMM method is also less sensitive to noise in individ-
ual histone modifications. As shown in Figure 2(A) the
profile method failed to find a TSS where H3K3me3 signal
is weak. The HMM method predicted this TSS by using all
the histone marks. In Figure 2(B) the HMM method pre-
dicted an enhancer that is supported by both p300 and
DHS sites. Weak signal of H3K4me3 may cause the failure
of the profile based method of identifying this site. An
opposite example is shown in Figure 2(C) where a rela-
tively stronger H3K4me3 signal than typical enhancers
prevents identification of DHS site to be enhancers by the
profile-based method while the HMM method was not
affected.
In the present work, we did not further distinguish sub-
clusters of promoters and enhancers as in the study of
Heintzman et al. to avoid overfitting. It is very likely that
promoter and enhancers may have distinct histone modi-
fication patterns depending upon their functional state
(active, repressed or poised) [26]. As histone modification
data are becoming available on more histone marks and
on the entire human genome [6], it is possible to train
separate or refined HMMs for promoter/enhancer in dif-
ferent functional states, which should further improve the
performance of our model.
We also demonstrated the success of our approach on
analyzing ChIP-Seq data. By including chromatin marks
that are characteristics of transcription, our method could
successfully predicted the activities of promoters. If anno-
tated enhancers are available for training the HMMs, it is
straightforward to extend our predictions to enhancers.
With the fast accumulation of chromatin modification
data, we believe that our method will provide a useful tool
in systematically mapping regulatory elements.
Methods
Data Preparation
The histone modification data were obtained from the
Heintzman  et al. study [15]. The averaged profile and
individual histone marks are shown in Figure 1, compar-
ing the histone patterns on promoter and enhancer. We
followed their smoothing procedure. Data were grouped
into 100 bp bins and the values of probes within each bin
were averaged, e.g. a histone pattern of 2 Kb consists of 20
bins. The regions not covered by probes were linearly
interpolated if the size of the uncovered region is less than
1000 bp. Heintzman et al. studied histone modifications
in both untreated HeLa cells and HeLa cells treated with
IFN. To design a classifier, HMMs were trained on pro-
moters, enhancers and background, respectively. Previous
studies demonstrated that p300 and related acetyltrans-
ferases are present at enhancers and promoters[23].
Heintzman et al. determined 124 and 182 p300 binding
sites in the untreated and treated HeLa cells, respectively.
We used 74 p300 binding sites in the untreated cells after
removing those within 2.5 kb of the known 5' ends of
genes. These sites were enriched with DNaseI hypersensi-
tive sites (69.7%) and over 60% of them were conserved
across species [15]. These evidences strongly support that
distal p300 binding sites represent a subset of enhancers.
Heintzman  et al. used 106 active promoters in the
untreated cells that were centered at annotated RefSeq
TSSs as their training data for promoters [15]. In the cur-
rent study, one promoter and one enhancer were deleted
from the training set used by Heintzman et al. because
they included many unprobed regions.
While Heintzman et al. only tested on the window size of
10 kb centered on TSS and p300 binding sites, we tested
various window size. The candidate window sizes of his-
tone marks for the HMM-SA procedure were 1, 2, 4, 6, 8,
10, and 12 kb. Once the optimal window size 2 kb was
selected by HMM-SA, all the training dataset of 105 pro-
moters and 73 enhancers were used to train HMMs to pre-
dict promoters and enhancers in the ENCODE regions.
The histone patterns in the cell treated with IFN were
used as an independent test set.
The HMM classifier
We designed an HMM() with left-right structure[17] to
represent the histone modification patterns. Left-right
structure has been widely used in speech recognition toBMC Bioinformatics 2008, 9:547 http://www.biomedcentral.com/1471-2105/9/547
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capture signal pattern, which serves well for our purpose
of capturing histone modification patterns. The HMM has
Q states (Figure 7). An HMM state emits a signal according
to a probability density function of mixture Gaussian of N
dimension. Here N is the number of histone modification
patterns under consideration. The probability density
function of the mixture Gaussian is
where x is the vector being modeled and cjm is the mixture
coefficient for the mth Gaussian in state j; G [x, jm, Ujm]
represents the Gaussian function with mean vector jm
and covariance matrix Ujm. The forward and backward
algorithm[17] was used to estimate the transition proba-
bilities and the mixture coefficients in each state. We
trained three HMMs for promoters, enhancers and back-
ground separately. We set Q = (number of bins)/k to change
the number of states depending on the length of data (we
set k = 8) and the minimum Q was set to 3. The back-
ground HMM was designed to have the minimum
number of states (Q = 3). Each state is composed of 3 mix-
bc G j Q jj m j m j m
m
M
() [, , ] , xx =≤ ≤
= ∑   U
1
1
The HMM Classifier Figure 7
The HMM Classifier. (a) A left-right HMM with Q states. Each state has a transition to itself and outgoing transitions toward 
higher states behind. Once a state is left it never comes back in a left-right model. (b) Three HMMs are trained separately for 
promoter, enhancer and background. Log-odds are calculated to classify a genomic region (see Methods).BMC Bioinformatics 2008, 9:547 http://www.biomedcentral.com/1471-2105/9/547
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tures of Gaussian components (M = 3) to capture the com-
plex histone modification patterns. Models with larger m
did not improve the prediction performance (data not
shown).
For a given genomic region, a log likelihood score was cal-
culated using the three HMMs for promoter, enhancer and
background. Two log-odd scores were calculated as the
following.
The log-odd score reflects how strong a signal is compared
to the background. If the log-odd is below a cutoff (c1, c2),
it is regarded as a background signal. The number of pre-
diction depends on these cut-off values. We plotted Figure
3 and 6 while changing the cut-off values.
When we scan the ENCODE regions, we smoothed results
by averaging adjacent 3 log-odds and took peaks of the
log-odds of promoter over enhancer. This smoothing pro-
cedure reduced fluctuations of log-odds along the chro-
mosome, especially at the boundaries of the unprobed
regions. If multiple predictions were made within 1.5
Kbp, only the prediction with the highest log-odds was
kept. If a promoter and an enhancer were predicted within
1.5 Kb, we only kept the prediction with the higher log-
odd. We examined the percentage of promoters and
enhancers being correctly predicted while varying the cut-
off values c1 and c2 (Figure 3, Figure 6 and Table 4). Using
six histone marks we observed the same number of pre-
diction of the HMM predictor as the profile-based method
when c1 = 2.205 (untreated) and c1 = 2.1 (treated). We
used c2 = 0.25 (untreated) and c2 = 0.0 (treated) to com-
pare the prediction result of the enhancer (Table 6).
Search for the most informative histone modification 
combination
Automatic search for the most informative combination
of histone modification is a typical feature selection prob-
lem. We took an approach that couples HMM with simu-
lated annealing (SA) to find the optimal combination. SA
[16] is a generic approach for global optimization prob-
lems. Incorporating a temperature parameter into the
optimization procedure, it explores broad parameter
space at high temperatures and restricts exploration at
lower temperatures. The simulated annealing updates
were made based on the Metropolis criterion. The Metrop-
olis criterion makes a change from Ecurrent to E with a prob-
ability of
That is, if Ecurrent is greater than the previous value (E), the
move is always accepted; otherwise, the move is accepted
with a probability of   that decreases
with T.
To adapt the SA method to our model, we hybridized
HMMs with SA. Initially, SA randomly selected a candi-
date combination of histone modifications. Also, a win-
dow size was randomly selected among 1, 2, 4, 6, 8, 10, 12
Kbp. An HMM was trained with the candidate combina-
tion and evaluated by Ecurrent. Ecurrent is defined as:
Ecurrent = (sensitivity of promoter × 100) + (sensitivity of 
enhancer × 100). (4)
The combination is accepted with the probability given in
equation (3). Ecurrent is always accepted if Ecurrent>E; other-
wise, it is accepted with a probability that generally
decreases as the temperature (T) decreases. The next move
is made by randomly adding or removing one or two his-
tone patterns and increasing or decreasing one 2 Kb of the
window size. This procedure is repeated while decreasing
the temperature T. In the simulation we used
T = 0.9iteration (5)
In the HMM-SA procedure, the 105 promoter and 73
enhancers in the training dataset was divided into training
and evaluation sets, half of them were used to train the
HMMs and the other half to calculate Ecurrent. The training
set (52 promoters and 36 enhancers) and the test set are
fixed for each run. We set the maximum number of itera-
tions to be 200 to give SA enough burning period. In fact,
most simulations were converged in less than 100 itera-
tions. We recorded the results for 30 independent simula-
tions.
Evaluating predictions
We validated the prediction results in the ENCODE
regions by calculating how many predicted promoters are
supported by annotated TSSs in RefSeq. The adjacent 3
log-odds (1, 2) are averaged. If multiple peaks of promot-
ers or enhancers are found within 1.5 kb, only the highest
log-odd is selected. A prediction was considered as correct
if the predicted center is within D = 2.5 kb to the closest
annotated TSS of a gene. When multiple predicted sites
are supported by the same TSS or any enhancer evidence,
log-odd for promoter
(
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we merge these predictions. However, when multiple pre-
dicted sites are not within the distance, we counted all of
them as FPs. The total number of the predicted promoters
in Heintzman et al[15] was 208. Since two promoters are
referred to the same gene, we treated these two promoters
as one and thus the total number of predictions becomes
207. We defined PPV = TP/(TP+FP).
To compare the performance of the two methods, we plot-
ted ROC curves for promoter predictions in both
untreated and treated cells (Figure 5). We defined FN as
the number of active promoters that were missed in our
predictions. It is not very straightforward to define true
negatives. We chose to divide the entire ENCODE regions
into 2.5 kb-long non-overlapping segments. There were
9928 segments in which no annotated TSSs were found
within ± 2.5 kb. We defined TN as the number of seg-
ments that did not contain any predicted promoters. The
sensitivity and the specificity were given as TP/(TP+FN)
and TN/(FP+TN), respectively.
ChIP-Seq data in the three mouse cell lines
Mikkelsen et al. generated the genome-wide mapping of
chromatin modifications in three mouse cell lines: embry-
onic stem (ES) cells, neural progenitor cells (NPCs) and
embryonic fibroblasts (MEFs) [8]. Four chromatin marks,
H3K4me3, H9K4me3, H3K27me3, and H3K36me3, were
measured in all these cell lines. We trained a HMM classi-
fier using the chromatin modification patterns around
TSS in the ES cells and tested it in all three cell lines. Based
on the gene expression measured by Mikkelsen et al., we
randomly selected 200 active and 200 inactive promoters
in the ES cells as the training set. Because there were only
four chromatin marks, we used all of them in the HMM
model. Similar to analysis of ChIP-chip data, we first used
a 2 Kb window to locate TSSs in the genome (see above).
Considering the spread out pattern of H3K36me3 that
distinguishes active from inactive promoters (Figure S2,
see Additional file 7), we next used a 10 Kb window to
classify the predicted promoters into active or inactive cat-
egory. A background HMM was trained using the sequenc-
ing reads mapped to chromosome 1.
We evaluated the classification performance of our
method using gene expression and RefSeq annotation on
predictions that could be unambiguously assigned to a
gene, namely located 2.5 Kb within an annotated TSS.
Mikkelsen et. al conducted replicate measurements of
gene expression in the same cell lines (GEO accession
number is GSE8024). There were 13482 unique genes in
their experiments. The numbers of active and inactive
genes in each cell line were counted using the majority
rule in the replicate experiments and the genes with mar-
ginal expression levels or conflicting calls were excluded
(Table 7).
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Figure S2 Active and inactive profile of the ChIP-Seq data. Tag counts 
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